Engineered αvβ6-targeting peptide‒BSH conjugates for boron neutron capture therapy of pancreatic ductal adenocarcinoma
Acta Pharmaceutica Sinica B · 2026-11 · 16 (11) · 7535-7553
DOI: 10.1016/j.apsb.2026.05.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-11. Verfasst von Linger Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and P…. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese Academy of Medical Sciences, National Natural Science Foundation of China, Beijing Nova Program.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
- Beijing Key Laboratory of Targeted Radiopharmaceutical Development and Translational Nuclear Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, Chi…
- Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China.
- China Spallation Neutron Source Center, Dongguan 523803, China.
- Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences & Research Unit of Peptide Science, Chinese Academy of Medical Sciences, Lanzhou University, Lanzhou 730000, China.
Förderung
- Chinese Academy of Medical Sciences
- National Natural Science Foundation of China
- Beijing Nova Program
- Natural Science Foundation of Beijing Municipality
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
Zitieren
APA
Li, L., Gao, X., Zhang, S., Wang, X., Chen, X., Miao, Y., Zhang, T., Yang, M., Liu, C., Liang, T., Yi, T., Jiang, S., Huang, H., Zhang, H., Tong, J., Wang, R., & Hu, K. (2026). Engineered αvβ6-targeting peptide‒BSH conjugates for boron neutron capture therapy of pancreatic ductal adenocarcinoma. Acta Pharmaceutica Sinica B, 16(11), 7535-7553. https://doi.org/10.1016/j.apsb.2026.05.012
Vancouver
Li L, Gao X, Zhang S, Wang X, Chen X, Miao Y, et al. Engineered αvβ6-targeting peptide‒BSH conjugates for boron neutron capture therapy of pancreatic ductal adenocarcinoma. Acta Pharmaceutica Sinica B. 2026;16(11):7535-7553. doi:10.1016/j.apsb.2026.05.012
BibTeX
@article{Li2026,
author = {Li, Linger and Gao, Xin and Zhang, Siqi and Wang, Xingkai and Chen, Xueyao and Miao, Yuan and Zhang, Tongtong and Yang, Mengjie and Liu, Can and Liang, Tianjiao and Yi, Tiancheng and Jiang, Shuo and Huang, Hongyi and Zhang, Hailong and Tong, Jianfei and Wang, Rui and Hu, Kuan},
title = {Engineered αvβ6-targeting peptide‒BSH conjugates for boron neutron capture therapy of pancreatic ductal adenocarcinoma},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
volume = {16},
number = {11},
pages = {7535--7553},
doi = {10.1016/j.apsb.2026.05.012}
}
EUVIMED